Nicole C. Murphy
Head of Pharmaceutical Operations and Technology
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Biogen Inc. (BIIB) | Head of Pharmaceutical Operations and Technology | $909,109 | $7,575,505 |
| 2024 | Biogen Inc. (BIIB) | Head of Pharmaceutical Operations and Technology | $764,567 | $5,740,359 |
| 2023 | Biogen Inc. (BIIB) | Head of Pharmaceutical Operations and Technology | $670,642 | $5,714,319 |
| 2022 | Biogen Inc. (BIIB) | Head of Pharmaceutical Operations and Technology | $592,218 | $4,929,712 |
Earnings-call appearances
No earnings-call appearances recorded yet.